From “The Way Forward" Conference: Dr. Leonard S. Schleifer, Co-Founder, Regeneron Pharmaceuticals

Trump approves Regeneron antibody treatmentПодробнее

Q & A with Regeneron CEO, Dr. Leonard Schleifer '73 - 2019 Cornell Entrepreneur of the YearПодробнее

Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer | Mad Money | CNBCПодробнее

Leonard S. Schleifer, M.D., Ph.D., Founder and Chief Executive Officer, Regeneron PharmaceuticalsПодробнее

From “The Way Forward" Conference: David Rubenstein, Co-Founder, The Carlyle GroupПодробнее

From “The Way Forward" Conference: Sarah Friar, CEO, NextdoorПодробнее

Regeneron CEO Leonard Schleifer: Changing The Paradigm On Drug Access And Pricing | CNBCПодробнее

Leonard SchleiferПодробнее

From “The Way Forward" Conference: Dr. Leonard S. Schleifer, Co-Founder, Regeneron PharmaceuticalsПодробнее

Leonard S. Scheifler - Takeaway 1Подробнее

From “The Way Forward" Conference: Mike Roman, Chairman and CEO, 3MПодробнее

From “The Way Forward" Conference: Dr. Stephen J. Corwin, President and CEO, New York-PresbyterianПодробнее

From “The Way Forward" Conference: Rick Rieder, CIO of Global Fixed Income, BlackRockПодробнее

From “The Way Forward" Conference: Ed Bastian, CEO, Delta Air LinesПодробнее

From “The Way Forward" Conference: Kevin Johnson, President and CEO, Starbucks Coffee CompanyПодробнее

From “The Way Forward" Conference: Jon Gray, President and COO, BlackstoneПодробнее

Regeneron CEO: Our antibody treatment helps immune system win battleПодробнее

Regeneron Pharmaceuticals CEO Dr. Len Schleifer about vaccine and antibody therapy treatmentПодробнее

The Cholesterol Drug Of The Future? | ForbesПодробнее